Documento completo  |  Capítulo completo  |  Expandir índice  |  Versión HTML imprimible
The Quality of Antimalarials - A Study in Selected African Countries - EDM Research Series No. 030
(2003; 67 pages) Ver el documento en el formato PDF
Índice de contenido
Ver el documentoAuthors
Ver el documentoCountry Research Team Leaders
Ver el documentoLaboratory Support
Ver el documentoAcknowledgements
Ver el documentoAcronyms
Ver el documentoExecutive summary
Ver el documento1. Background
Abrir esta carpeta y ver su contenido2. Methodology
Ver el documento3. Results
Abrir esta carpeta y ver su contenido4. Discussion
Abrir esta carpeta y ver su contenido5. Conclusions and recommendations
Ver el documentoReferences
Abrir esta carpeta y ver su contenidoTables
Abrir esta carpeta y ver su contenidoAnnexes
Ver el documentoOther documents in the EDM Research Series
Ver el documentoEDM Research Series No. 30
 

EDM Research Series No. 30

The Department of Essential Drugs and Medicines Policy (EDM) of the World Health Organization works to ensure that all people ⊥ wherever they may be ⊥ are able to obtain the drugs they need at a price that they and their country can afford, that these medicines are safe

Ensuring access to and rational use of medicines for all people is a difficult goal in itself, especially given today’s rapidly changing macroeconomic and national environments. Countries are experiencing the impacts of structural adjustment policies, globalization of world markets and new disease patterns. Widespread health system reforms with shifting priorities, and the changing relationship between the public and private sectors, further complicate this picture. Additionally, many governments lack crucial information to guide their national medicines policies in response to these challenges.

But operational research is making a vital contribution to identifying global and national drug sector problems and priority areas for intervention. At global level, the systematic development and analysis of internationally comparable data on pharmaceutical systems is enabling countries to learn from each other's experience and to strengthen their national drug policies. At the same time, national research is helping countries to analyse and overcome the constraints they face in developing and implementing these policies.

This document is just one in a series of research guidelines and studies that are helping to reduce the burden of disease and provide access to responsive health care for all.

Department of Essential Drugs and Medicines Policy, World Health Organization, 1211 Geneva 27, Switzerland

Ir a la sección anterior
 
 
El Portal de Información - Medicamentos Esenciales y Productos de Salud de la OMS fue diseñado y es mantenido por la ONG Human Info. Última actualización: le 29 octubre 2018